<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36231090</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>19</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>C9-ALS-Associated Proline-Arginine Dipeptide Repeat Protein Induces Activation of NLRP3 Inflammasome of HMC3 Microglia Cells by Binding of Complement Component 1 Q Subcomponent-Binding Protein (C1QBP), and Syringin Prevents This Effect.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3128</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells11193128</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal disease in which motor neurons gradually degenerate. The mutation of the <i>C9orf72</i> gene is the main genetic cause of ALS (C9-ALS). One of its specific pathological features is the production of proline-arginine (PR) dipeptide repeat protein (DPR). In this study, we developed a PR-DPR (PR<sub>50</sub>)-expressing human HMC3 microglial cell model. We found that PR<sub>50</sub> mainly aggregates into spots in the nucleus and induces significant NLRP3 inflammasome activity. Moreover, mouse NSC-34 motor neuron cells treated with a conditional medium of PR<sub>50</sub>-expressing HMC3 cells (PR-CM) caused cell damage and apoptosis activity. However, R<sub>50</sub>-expressing HMC cells treated with MCC950 (an NLRP3 inhibitor) reversed this result. Furthermore, we identified complement component 1 q subcomponent-binding protein (C1QBP) as one of the interaction partners of PR<sub>50</sub>. The downregulation of C1QBP in HMC3 cells induces NLRP3 inflammasome activity similar to PR<sub>50</sub> expression. Finally, we found that syringin can block the interaction between PR<sub>50</sub> and C1QBP, and effectively reduce the PR<sub>50</sub>-induced NLRP3 inflammasome activity in HMC3 cells. This improves the apoptosis of NSC-34 cells caused by PR-CM. This study is the first to link PR<sub>50</sub>, C1QBP, and NLRP3 inflammasome activity in microglia and develop potential therapeutic strategies for syringin intervention in C9-ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Ru-Huei</ForeName><Initials>RH</Initials><Identifier Source="ORCID">0000-0001-9367-1759</Identifier><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Medicine Research Center, China Medical University Hospital, Taichung 40447, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Chia-Wen</ForeName><Initials>CW</Initials><Identifier Source="ORCID">0000-0003-0101-5696</Identifier><AffiliationInfo><Affiliation>Department of Nutrition, China Medical University, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Shao-Chih</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shih-Ping</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Medicine Research Center, China Medical University Hospital, Taichung 40447, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiang</LastName><ForeName>Yu-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Yun-Hua</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shyu</LastName><ForeName>Woei-Cherng</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Medicine Research Center, China Medical University Hospital, Taichung 40447, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shinn-Zong</ForeName><Initials>SZ</Initials><Identifier Source="ORCID">0000-0002-4601-9933</Identifier><AffiliationInfo><Affiliation>Buddhist Tzu Chi Bioinnovation Center, Tzu Chi Foundation, Hualien 97002, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Buddhist Tzu Chi General Hospital, Hualien 97002, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C087299">C1QBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C490193">C1qbp protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003172">Complement C1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005960">Glucosides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071199">NLR Family, Pyrin Domain-Containing 3 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C492716">Nlrp3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010666">Phenylpropionates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical><Chemical><RegistryNumber>9DLQ4CIU6V</RegistryNumber><NameOfSubstance UI="D011392">Proline</NameOfSubstance></Chemical><Chemical><RegistryNumber>I6F5B11C96</RegistryNumber><NameOfSubstance UI="C028305">syringin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003172" MajorTopicYN="N">Complement C1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005960" MajorTopicYN="N">Glucosides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="N">Mitochondrial Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071199" MajorTopicYN="N">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010666" MajorTopicYN="N">Phenylpropionates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011392" MajorTopicYN="N">Proline</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">HMC3 microglia cell</Keyword><Keyword MajorTopicYN="N">NLRP3 inflammasome</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">complement component 1 q subcomponent-binding protein (C1QBP)</Keyword><Keyword MajorTopicYN="N">mouse motor neuron NSC34 cell</Keyword><Keyword MajorTopicYN="N">proline-arginine dipeptide repeat protein (PR-DPR)</Keyword><Keyword MajorTopicYN="N">syringin</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>1</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36231090</ArticleId><ArticleId IdType="pmc">PMC9563448</ArticleId><ArticleId IdType="doi">10.3390/cells11193128</ArticleId><ArticleId IdType="pii">cells11193128</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman S.A., Hardiman O., Al-Chalabi A., Chio A., Savelieff M.G., Kiernan M.C., Feldman E.L. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:465&#x2013;479. doi: 10.1016/S1474-4422(21)00414-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00414-2</ArticleId><ArticleId IdType="pmc">PMC9513754</ArticleId><ArticleId IdType="pubmed">35334234</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>St Martin J.L., Wang L., Kaprielian Z. Toxicity in ALS: TDP-43 modifiers and C9orf72. Neurosci. Lett. 2020;716:134621. doi: 10.1016/j.neulet.2019.134621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134621</ArticleId><ArticleId IdType="pubmed">31726180</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd T.W., McEachin Z.T., Chew J., Burch A.R., Jansen-West K., Tong J., Yue M., Song Y., Castanedes-Casey M., Kurti A., et al. Hexanucleotide Repeat Expansions in c9FTD/ALS and SCA36 Confer Selective Patterns of Neurodegeneration in Vivo. Cell Rep. 2020;31:107616. doi: 10.1016/j.celrep.2020.107616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107616</ArticleId><ArticleId IdType="pmc">PMC7480900</ArticleId><ArticleId IdType="pubmed">32375043</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Taylor J.P. The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD. Front. Mol. Neurosci. 2017;10:35. doi: 10.3389/fnmol.2017.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Tan W., Westergard T., Krishnamurthy K., Markandaiah S.S., Shi Y., Lin S., Shneider N.A., Monaghan J., Pandey U.B., et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84:1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gronke S., Niccoli T., Ridler C.E., Clayton E.L., Devoy A., Moens T., Norona F.E., Woollacott I.O.C., Pietrzyk J., et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Z., Liu L., Tao Z., Wang R., Ren H., Sun H., Lin Z., Zhang Z., Mu C., Zhou J., et al. Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR. Nat. Commun. 2019;10:2906. doi: 10.1038/s41467-019-10956-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10956-w</ArticleId><ArticleId IdType="pmc">PMC6606620</ArticleId><ArticleId IdType="pubmed">31266945</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z., Wang H., Xia Q., Li K., Li K., Jiang X., Xu G., Wang G., Ying Z. Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity. Hum. Mol. Genet. 2015;24:2426&#x2013;2441. doi: 10.1093/hmg/ddv005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv005</ArticleId><ArticleId IdType="pubmed">25575510</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Shibagaki Y., Hattori S., Matsuoka M. The proline-arginine repeat protein linked to C9-ALS/FTD causes neuronal toxicity by inhibiting the DEAD-box RNA helicase-mediated ribosome biogenesis. Cell Death Dis. 2018;9:975. doi: 10.1038/s41419-018-1028-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1028-5</ArticleId><ArticleId IdType="pmc">PMC6155127</ArticleId><ArticleId IdType="pubmed">30250194</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.R., Mitrea D.M., Zhang P., Stanley C.B., Cassidy D.E., Nourse A., Phillips A.H., Tolbert M., Taylor J.P., Kriwacki R.W. C9orf72 Poly(PR) Dipeptide Repeats Disturb Biomolecular Phase Separation and Disrupt Nucleolar Function. Mol. Cell. 2019;74:713&#x2013;728 e6. doi: 10.1016/j.molcel.2019.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.03.019</ArticleId><ArticleId IdType="pmc">PMC6525025</ArticleId><ArticleId IdType="pubmed">30981631</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Bao P., Jiang X., Wang H., Qin M., Wang R., Wang T., Yang Y., Lorenzini I., Liao L., et al. Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity. Brain. 2019;142:1349&#x2013;1364. doi: 10.1093/brain/awz070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz070</ArticleId><ArticleId IdType="pmc">PMC6487333</ArticleId><ArticleId IdType="pubmed">30938419</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Matsuoka M. Proline-arginine poly-dipeptide encoded by the C9orf72 repeat expansion inhibits adenosine deaminase acting on RNA. J. Neurochem. 2021;158:753&#x2013;765. doi: 10.1111/jnc.15445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15445</ArticleId><ArticleId IdType="pubmed">34081786</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S., Lopez-Gonzalez R., Kunz R.C., Gangopadhyay J., Borufka C., Gygi S.P., Gao F.B., Reed R. Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-splicing in ALS/FTD Patients. Cell Rep. 2017;19:2244&#x2013;2256. doi: 10.1016/j.celrep.2017.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.056</ArticleId><ArticleId IdType="pmc">PMC5653973</ArticleId><ArticleId IdType="pubmed">28614712</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.S., Chung C.G., Park J.H., Ko B.S., Park S.S., Kim Y.H., Cha I.J., Kim J., Ha C.M., Kim H.J., et al. C9orf72-associated arginine-rich dipeptide repeats induce RNA-dependent nuclear accumulation of Staufen in neurons. Hum. Mol. Genet. 2021;30:1084&#x2013;1100. doi: 10.1093/hmg/ddab089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab089</ArticleId><ArticleId IdType="pmc">PMC8188407</ArticleId><ArticleId IdType="pubmed">33783499</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Shibagaki Y., Hattori S., Matsuoka M. C9-ALS/FTD-linked proline-arginine dipeptide repeat protein associates with paraspeckle components and increases paraspeckle formation. Cell Death Dis. 2019;10:746. doi: 10.1038/s41419-019-1983-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1983-5</ArticleId><ArticleId IdType="pmc">PMC6776546</ArticleId><ArticleId IdType="pubmed">31582731</ArticleId></ArticleIdList></Reference><Reference><Citation>Maor-Nof M., Shipony Z., Lopez-Gonzalez R., Nakayama L., Zhang Y.J., Couthouis J., Blum J.A., Castruita P.A., Linares G.R., Ruan K., et al. p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR) Cell. 2021;184:689&#x2013;708 e20. doi: 10.1016/j.cell.2020.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7886018</ArticleId><ArticleId IdType="pubmed">33482083</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade N.S., Ramic M., Esanov R., Liu W., Rybin M.J., Gaidosh G., Abdallah A., Del&#x2019;Olio S., Huff T.C., Chee N.T., et al. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD. Mol. Neurodegener. 2020;15:13. doi: 10.1186/s13024-020-00365-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00365-9</ArticleId><ArticleId IdType="pmc">PMC7041170</ArticleId><ArticleId IdType="pubmed">32093728</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes L.R., Duan L., Bowen K., Kalab P., Rothstein J.D. C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import. Elife. 2020;9:e51685. doi: 10.7554/eLife.51685.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.51685</ArticleId><ArticleId IdType="pmc">PMC7051184</ArticleId><ArticleId IdType="pubmed">32119645</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi K.Y., Mori E., Nizami Z.F., Lin Y., Kato M., Xiang S., Wu L.C., Ding M., Yu Y., Gall J.G., et al. Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export. Proc. Natl. Acad. Sci. USA. 2017;114:E1111&#x2013;E1117. doi: 10.1073/pnas.1620293114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1620293114</ArticleId><ArticleId IdType="pmc">PMC5320981</ArticleId><ArticleId IdType="pubmed">28069952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Yagi T., Cammack A.J., Mahadevan J., Kuroda M., Harms M.B., Miller T.M., Urano F. Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation. Hum. Mol. Genet. 2016;25:1803&#x2013;1813. doi: 10.1093/hmg/ddw052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw052</ArticleId><ArticleId IdType="pmc">PMC4986334</ArticleId><ArticleId IdType="pubmed">26931465</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens T.G., Niccoli T., Wilson K.M., Atilano M.L., Birsa N., Gittings L.M., Holbling B.V., Dyson M.C., Thoeng A., Neeves J., et al. C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A. Acta Neuropathol. 2019;137:487&#x2013;500. doi: 10.1007/s00401-018-1946-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1946-4</ArticleId><ArticleId IdType="pmc">PMC6514073</ArticleId><ArticleId IdType="pubmed">30604225</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Xu J. C9orf72 Dipeptide Repeats Cause Selective Neurodegeneration and Cell-Autonomous Excitotoxicity in Drosophila Glutamatergic Neurons. J. Neurosci. 2018;38:7741&#x2013;7752. doi: 10.1523/JNEUROSCI.0908-18.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0908-18.2018</ArticleId><ArticleId IdType="pmc">PMC6705968</ArticleId><ArticleId IdType="pubmed">30037833</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo Y., Lee J., Lee S.Y., Kwon I., Cho H. Poly-dipeptides produced from C9orf72 hexanucleotide repeats cause selective motor neuron hyperexcitability in ALS. Proc. Natl. Acad. Sci. USA. 2022;119:e2113813119. doi: 10.1073/pnas.2113813119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113813119</ArticleId><ArticleId IdType="pmc">PMC8931230</ArticleId><ArticleId IdType="pubmed">35259014</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Xu X., Hao Z., Zhang S., Wu D., Sun H., Mu C., Ren H., Wang G. Poly-PR in C9ORF72-Related Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Causes Neurotoxicity by Clathrin-Dependent Endocytosis. Neurosci. Bull. 2019;35:889&#x2013;900. doi: 10.1007/s12264-019-00395-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-019-00395-4</ArticleId><ArticleId IdType="pmc">PMC6754483</ArticleId><ArticleId IdType="pubmed">31148094</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu M., Favretto F., de Opakua A.I., Rankovic M., Becker S., Zweckstetter M. Proline/arginine dipeptide repeat polymers derail protein folding in amyotrophic lateral sclerosis. Nat. Commun. 2021;12:3396. doi: 10.1038/s41467-021-23691-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23691-y</ArticleId><ArticleId IdType="pmc">PMC8184751</ArticleId><ArticleId IdType="pubmed">34099711</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli L., Young F.L., Boeynaems S., De Decker M., Mehta A.R., Swijsen A., Fazal R., Guo W., Moisse M., Beckers J., et al. C9orf72-derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility. Sci. Adv. 2021;7:eabg3013. doi: 10.1126/sciadv.abg3013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg3013</ArticleId><ArticleId IdType="pmc">PMC8034861</ArticleId><ArticleId IdType="pubmed">33837088</ArticleId></ArticleIdList></Reference><Reference><Citation>Premasiri A.S., Gill A.L., Vieira F.G. Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat Toxicity. Front. Pharmacol. 2020;11:569661. doi: 10.3389/fphar.2020.569661.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.569661</ArticleId><ArticleId IdType="pmc">PMC7508178</ArticleId><ArticleId IdType="pubmed">33013410</ArticleId></ArticleIdList></Reference><Reference><Citation>Trageser K.J., Smith C., Herman F.J., Ono K., Pasinetti G.M. Mechanisms of Immune Activation by c9orf72-Expansions in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Neurosci. 2019;13:1298. doi: 10.3389/fnins.2019.01298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01298</ArticleId><ArticleId IdType="pmc">PMC6914852</ArticleId><ArticleId IdType="pubmed">31920478</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., Baloh R.H. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137:715&#x2013;730. doi: 10.1007/s00401-018-1933-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Haukedal H., Freude K. Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. J. Mol. Biol. 2019;431:1818&#x2013;1829. doi: 10.1016/j.jmb.2019.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.02.004</ArticleId><ArticleId IdType="pubmed">30763568</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Beckers J., Gossye H., Van Damme P. The role of inflammation in neurodegeneration: Novel insights into the role of the immune system in C9orf72 HRE-mediated ALS/FTD. Mol. Neurodegener. 2022;17:22. doi: 10.1186/s13024-022-00525-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00525-z</ArticleId><ArticleId IdType="pmc">PMC8932121</ArticleId><ArticleId IdType="pubmed">35303907</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A., Wells M.F., Limone F., Couto A., Smith K.S., Keaney J., Gillet G., van Gastel N., Wang J.Y., Pietilainen O., et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582:89&#x2013;94. doi: 10.1038/s41586-020-2288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., O&#x2019;Rourke J.G., Yanez A., Markman J.L., Ho R., Wang X., Chen S., Lall D., Jin M., Muhammad A., et al. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature. 2020;585:96&#x2013;101. doi: 10.1038/s41586-020-2625-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2625-x</ArticleId><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="pubmed">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostalski H., Leskela S., Huber N., Katisko K., Cajanus A., Solje E., Marttinen M., Natunen T., Remes A.M., Hiltunen M., et al. Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS. Front. Neurosci. 2019;13:486. doi: 10.3389/fnins.2019.00486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00486</ArticleId><ArticleId IdType="pmc">PMC6529740</ArticleId><ArticleId IdType="pubmed">31156371</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner F., Molawi K., Zychlinsky A. Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc. Natl. Acad. Sci. USA. 2010;107:13046&#x2013;13050. doi: 10.1073/pnas.1002396107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002396107</ArticleId><ArticleId IdType="pmc">PMC2919927</ArticleId><ArticleId IdType="pubmed">20616033</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Bell S., Wang J., Wen S., Baloh R.H., Appel S.H. TDP-43 activates microglia through NF-kappaB and NLRP3 inflammasome. Exp. Neurol. 2015;273:24&#x2013;35. doi: 10.1016/j.expneurol.2015.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.07.019</ArticleId><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson K.V., Deng M., Ting J.P. The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 2019;19:477&#x2013;489. doi: 10.1038/s41577-019-0165-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0165-0</ArticleId><ArticleId IdType="pmc">PMC7807242</ArticleId><ArticleId IdType="pubmed">31036962</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Xia Y., Yin S., Wan F., Hu J., Kou L., Sun Y., Wu J., Zhou Q., Huang J., et al. Targeting Microglial alpha-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson&#x2019;s Disease. Front. Immunol. 2021;12:719807. doi: 10.3389/fimmu.2021.719807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.719807</ArticleId><ArticleId IdType="pmc">PMC8531525</ArticleId><ArticleId IdType="pubmed">34691027</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Zeng W., Zhang Y., Yu Q., Zeng M., Gan J., Zhang W., Jiang X., Li H. Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke (Review) Int. J. Mol. Med. 2022;49:74. doi: 10.3892/ijmm.2022.5130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2022.5130</ArticleId><ArticleId IdType="pmc">PMC9015651</ArticleId><ArticleId IdType="pubmed">35419616</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque M.E., Akther M., Jakaria M., Kim I.S., Azam S., Choi D.K. Targeting the microglial NLRP3 inflammasome and its role in Parkinson&#x2019;s disease. Mov. Disord. 2020;35:20&#x2013;33. doi: 10.1002/mds.27874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27874</ArticleId><ArticleId IdType="pubmed">31680318</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagulenko V., Vitak N., Vajjhala P.R., Vince J.E., Stacey K.J. Caspase-1 Is an Apical Caspase Leading to Caspase-3 Cleavage in the AIM2 Inflammasome Response, Independent of Caspase-8. J. Mol. Biol. 2018;430:238&#x2013;247. doi: 10.1016/j.jmb.2017.10.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2017.10.028</ArticleId><ArticleId IdType="pubmed">29100888</ArticleId></ArticleIdList></Reference><Reference><Citation>Deora V., Lee J.D., Albornoz E.A., McAlary L., Jagaraj C.J., Robertson A.A.B., Atkin J.D., Cooper M.A., Schroder K., Yerbury J.J., et al. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia. 2020;68:407&#x2013;421. doi: 10.1002/glia.23728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23728</ArticleId><ArticleId IdType="pubmed">31596526</ArticleId></ArticleIdList></Reference><Reference><Citation>Piancone F., La Rosa F., Marventano I., Saresella M., Clerici M. The Role of the Inflammasome in Neurodegenerative Diseases. Molecules. 2021;26:953. doi: 10.3390/molecules26040953.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26040953</ArticleId><ArticleId IdType="pmc">PMC7916884</ArticleId><ArticleId IdType="pubmed">33670164</ArticleId></ArticleIdList></Reference><Reference><Citation>Casarotto E., Sproviero D., Corridori E., Gagliani M.C., Cozzi M., Chierichetti M., Cristofani R., Ferrari V., Galbiati M., Mina F., et al. Neurodegenerative Disease-Associated TDP-43 Fragments Are Extracellularly Secreted with CASA Complex Proteins. Cells. 2022;11:516. doi: 10.3390/cells11030516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11030516</ArticleId><ArticleId IdType="pmc">PMC8833957</ArticleId><ArticleId IdType="pubmed">35159325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J.H., Alfatah M., Sin M.F., Sim H.M., Verma C.S., Lane D.P., Arumugam P. A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein-protein interactions identifies a novel putative Mdm2-binding site in p53. BMC Biol. 2017;15:108. doi: 10.1186/s12915-017-0446-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-017-0446-7</ArticleId><ArticleId IdType="pmc">PMC5680816</ArticleId><ArticleId IdType="pubmed">29121928</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D., Baloh R.H. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J. Clin. Invest. 2017;127:3250&#x2013;3258. doi: 10.1172/JCI90607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90607</ArticleId><ArticleId IdType="pmc">PMC5669558</ArticleId><ArticleId IdType="pubmed">28737506</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung H.J., Korm S., Lee S.I., Phorl S., Noh S., Han M., Naskar R., Kim H., Lee J.Y. RAP80 binds p32 to preserve the functional integrity of mitochondria. Biochem. Biophys. Res. Commun. 2017;492:441&#x2013;446. doi: 10.1016/j.bbrc.2017.08.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.08.077</ArticleId><ArticleId IdType="pubmed">28842250</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Huang C.L., Zhang Y. Complement C1q Binding Protein (C1QBP): Physiological Functions, Mutation-Associated Mitochondrial Cardiomyopathy and Current Disease Models. Front. Cardiovasc. Med. 2022;9:843853. doi: 10.3389/fcvm.2022.843853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.843853</ArticleId><ArticleId IdType="pmc">PMC8924301</ArticleId><ArticleId IdType="pubmed">35310974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghebrehiwet B., Geisbrecht B.V., Xu X., Savitt A.G., Peerschke E.I.B. The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)1. Semin. Immunol. 2019;45:101338. doi: 10.1016/j.smim.2019.101338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2019.101338</ArticleId><ArticleId IdType="pubmed">31744753</ArticleId></ArticleIdList></Reference><Reference><Citation>Egusquiza-Alvarez C.A., Robles-Flores M. An approach to p32/gC1qR/HABP1: A multifunctional protein with an essential role in cancer. J. Cancer Res. Clin. Oncol. 2022;148:1831&#x2013;1854. doi: 10.1007/s00432-022-04001-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-022-04001-5</ArticleId><ArticleId IdType="pubmed">35441886</ArticleId></ArticleIdList></Reference><Reference><Citation>Pednekar L., Valentino A., Ji Y., Tumma N., Valentino C., Kadoor A., Hosszu K.K., Ramadass M., Kew R.R., Kishore U., et al. Identification of the gC1qR sites for the HIV-1 viral envelope protein gp41 and the HCV core protein: Implications in viral-specific pathogenesis and therapy. Mol. Immunol. 2016;74:18&#x2013;26. doi: 10.1016/j.molimm.2016.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2016.03.016</ArticleId><ArticleId IdType="pmc">PMC4987126</ArticleId><ArticleId IdType="pubmed">27111569</ArticleId></ArticleIdList></Reference><Reference><Citation>Barna J., Dimen D., Puska G., Kovacs D., Csikos V., Olah S., Udvari E.B., Pal G., Dobolyi A. Complement component 1q subcomponent binding protein in the brain of the rat. Sci. Rep. 2019;9:4597. doi: 10.1038/s41598-019-40788-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-40788-z</ArticleId><ArticleId IdType="pmc">PMC6418184</ArticleId><ArticleId IdType="pubmed">30872665</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchiumi T., Kang D. Mitochondrial nucleic acid binding proteins associated with diseases. Front. Biosci. 2017;22:168&#x2013;179. doi: 10.2741/4479.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/4479</ArticleId><ArticleId IdType="pubmed">27814609</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.T., Xu X., Alontaga A.Y., Chen Y., Liu Y. Impaired p32 regulation caused by the lymphoma-prone RECQ4 mutation drives mitochondrial dysfunction. Cell Rep. 2014;7:848&#x2013;858. doi: 10.1016/j.celrep.2014.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.037</ArticleId><ArticleId IdType="pmc">PMC4029353</ArticleId><ArticleId IdType="pubmed">24746816</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., Sun H., Liang X., Lima W.F., Crooke S.T. Human RNase H1 is associated with protein P32 and is involved in mitochondrial pre-rRNA processing. PLoS ONE. 2013;8:e71006. doi: 10.1371/journal.pone.0071006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0071006</ArticleId><ArticleId IdType="pmc">PMC3750045</ArticleId><ArticleId IdType="pubmed">23990920</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wan O.W., Xie W., Chung K.K. p32 regulates mitochondrial morphology and dynamics through parkin. Neuroscience. 2011;199:346&#x2013;358. doi: 10.1016/j.neuroscience.2011.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2011.10.003</ArticleId><ArticleId IdType="pubmed">22008525</ArticleId></ArticleIdList></Reference><Reference><Citation>Reef S., Shifman O., Oren M., Kimchi A. The autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 protein. Oncogene. 2007;26:6677&#x2013;6683. doi: 10.1038/sj.onc.1210485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1210485</ArticleId><ArticleId IdType="pubmed">17486078</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao H., You H. p32: A new player in autophagy. Mol. Cell. Oncol. 2016;3:e1061097. doi: 10.1080/23723556.2015.1061097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23723556.2015.1061097</ArticleId><ArticleId IdType="pmc">PMC4909465</ArticleId><ArticleId IdType="pubmed">27314077</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh S., Phorl S., Naskar R., Oeum K., Seo Y., Kim E., Kweon H.S., Lee J.Y. p32/C1QBP regulates OMA1-dependent proteolytic processing of OPA1 to maintain mitochondrial connectivity related to mitochondrial dysfunction and apoptosis. Sci. Rep. 2020;10:10618. doi: 10.1038/s41598-020-67457-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-67457-w</ArticleId><ArticleId IdType="pmc">PMC7327069</ArticleId><ArticleId IdType="pubmed">32606429</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu M., Crawford S.A., Henstridge D.C., Ng I.H., Boey E.J., Xu Y., Febbraio M.A., Jans D.A., Bogoyevitch M.A. p32 protein levels are integral to mitochondrial and endoplasmic reticulum morphology, cell metabolism and survival. Biochem. J. 2013;453:381&#x2013;391. doi: 10.1042/BJ20121829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20121829</ArticleId><ArticleId IdType="pmc">PMC3727215</ArticleId><ArticleId IdType="pubmed">23692256</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayarajan J., Angandoor S., Vedulla S.H., Sritharan S., Ganesan K., War A.R., Sivalingam N. Curcumin induces chemosensitization to doxorubicin in Duke&#x2019;s type B coloadenocarcinoma cell line. Mol. Biol. Rep. 2020;47:7883&#x2013;7892. doi: 10.1007/s11033-020-05866-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05866-w</ArticleId><ArticleId IdType="pubmed">33025506</ArticleId></ArticleIdList></Reference><Reference><Citation>McGee A.M., Baines C.P. Complement 1q-binding protein inhibits the mitochondrial permeability transition pore and protects against oxidative stress-induced death. Biochem. J. 2011;433:119&#x2013;125. doi: 10.1042/BJ20101431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20101431</ArticleId><ArticleId IdType="pmc">PMC3512559</ArticleId><ArticleId IdType="pubmed">20950273</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L.J., Gu P.Q., Fan W.M., Liu Z., Qiu F., Peng Y.Z., Guo X.R. The role of gC1qR in regulating survival of human papillomavirus 16 oncogene-transfected cervical cancer cells. Int. J. Oncol. 2011;39:1265&#x2013;1272.</Citation><ArticleIdList><ArticleId IdType="pubmed">21725590</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi K., Koo B.H., Yoon B.J., Jung M., Yun H.Y., Jeon B.H., Won M.H., Kim Y.M., Mun J.Y., Lim H.K., et al. Overexpressed p32 localized in the endoplasmic reticulum and mitochondria negatively regulates calciumdependent endothelial nitric oxide synthase activit. Mol. Med. Rep. 2020;22:2395&#x2013;2403. doi: 10.3892/mmr.2020.11307.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.11307</ArticleId><ArticleId IdType="pmc">PMC7411372</ArticleId><ArticleId IdType="pubmed">32705193</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra S.R., Mahapatra K.K., Behera B.P., Patra S., Bhol C.S., Panigrahi D.P., Praharaj P.P., Singh A., Patil S., Dhiman R., et al. Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics. Int. J. Biochem. Cell. Biol. 2021;136:106013. doi: 10.1016/j.biocel.2021.106013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2021.106013</ArticleId><ArticleId IdType="pubmed">34022434</ArticleId></ArticleIdList></Reference><Reference><Citation>De Gaetano A., Solodka K., Zanini G., Selleri V., Mattioli A.V., Nasi M., Pinti M. Molecular Mechanisms of mtDNA-Mediated Inflammation. Cells. 2021;10:2898. doi: 10.3390/cells10112898.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10112898</ArticleId><ArticleId IdType="pmc">PMC8616383</ArticleId><ArticleId IdType="pubmed">34831121</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Li G., Luo R., Lei J., Song Y., Wang B., Ma L., Liao Z., Ke W., Liu H., et al. Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis. Exp. Mol. Med. 2022;54:129&#x2013;142. doi: 10.1038/s12276-022-00729-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-022-00729-9</ArticleId><ArticleId IdType="pmc">PMC8894389</ArticleId><ArticleId IdType="pubmed">35145201</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Zhou J.H., Zhang H., Canfran-Duque A., Singh A.K., Perry R.J., Shulman G., Fernandez-Hernando C., Min W. Brown adipose TRX2 deficiency activates mtDNA-NLRP3 to impair thermogenesis and protect against diet-induced insulin resistance. J. Clin. Invest. 2022;132:e148852. doi: 10.1172/JCI148852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI148852</ArticleId><ArticleId IdType="pmc">PMC9057632</ArticleId><ArticleId IdType="pubmed">35202005</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Li X., Wang J., Wang H. The Role of the Effects of Autophagy on NLRP3 Inflammasome in Inflammatory Nervous System Diseases. Front Cell Dev. Biol. 2021;9:657478. doi: 10.3389/fcell.2021.657478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.657478</ArticleId><ArticleId IdType="pmc">PMC8166298</ArticleId><ArticleId IdType="pubmed">34079796</ArticleId></ArticleIdList></Reference><Reference><Citation>Watthanasurorot A., Jiravanichpaisal P., Soderhall K., Soderhall I. A calreticulin/gC1qR complex prevents cells from dying: A conserved mechanism from arthropods to humans. J. Mol. Cell. Biol. 2013;5:120&#x2013;131. doi: 10.1093/jmcb/mjt005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjt005</ArticleId><ArticleId IdType="pubmed">23378602</ArticleId></ArticleIdList></Reference><Reference><Citation>Song K., Wu Y., Fu B., Wang L., Hao W., Hua F., Sun Y., Dorf M.E., Li S. Leaked Mitochondrial C1QBP Inhibits Activation of the DNA Sensor cGAS. J. Immunol. 2021;207:2155&#x2013;2166. doi: 10.4049/jimmunol.2100392.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100392</ArticleId><ArticleId IdType="pmc">PMC8492507</ArticleId><ArticleId IdType="pubmed">34526378</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebeaupin C., Proics E., de Bieville C.H., Rousseau D., Bonnafous S., Patouraux S., Adam G., Lavallard V.J., Rovere C., Le Thuc O., et al. ER stress induces NLRP3 inflammasome activation and hepatocyte death. Cell Death Dis. 2015;6:e1879. doi: 10.1038/cddis.2015.248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2015.248</ArticleId><ArticleId IdType="pmc">PMC4650444</ArticleId><ArticleId IdType="pubmed">26355342</ArticleId></ArticleIdList></Reference><Reference><Citation>Fort B.P., Dubyak G.R., Greenfield E.M. Lysosomal disruption by orthopedic wear particles induces activation of the NLRP3 inflammasome and macrophage cell death by distinct mechanisms. J. Orthop. Res. 2021;39:493&#x2013;505. doi: 10.1002/jor.24826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jor.24826</ArticleId><ArticleId IdType="pmc">PMC8201664</ArticleId><ArticleId IdType="pubmed">32779803</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv S., Li X., Wang H. The Role of the Effects of Endoplasmic Reticulum Stress on NLRP3 Inflammasome in Diabetes. Front Cell Dev. Biol. 2021;9:663528. doi: 10.3389/fcell.2021.663528.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.663528</ArticleId><ArticleId IdType="pmc">PMC8079978</ArticleId><ArticleId IdType="pubmed">33937267</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein S.R., Valsecchi F., Kawamata H., Bourens M., Zeng R., Zuberi A., Milner T.A., Cloonan S.M., Lutz C., Barrientos A., et al. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions. Hum. Mol. Genet. 2018;27:160&#x2013;177. doi: 10.1093/hmg/ddx397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx397</ArticleId><ArticleId IdType="pmc">PMC5886281</ArticleId><ArticleId IdType="pubmed">29112723</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H., Wu M., Wang Y., Du W., He Y., Shi Z. Total Syntheses and Anti-inflammatory Activities of Syringin and Its Natural Analogues. J. Nat. Prod. 2021;84:2866&#x2013;2874. doi: 10.1021/acs.jnatprod.1c00585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jnatprod.1c00585</ArticleId><ArticleId IdType="pubmed">34658231</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin L., Schmiech M., El Gaafary M., Zhang X., Syrovets T., Simmet T. A comparative study on root and bark extracts of Eleutherococcus senticosus and their effects on human macrophages. Phytomedicine. 2020;68:153181. doi: 10.1016/j.phymed.2020.153181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2020.153181</ArticleId><ArticleId IdType="pubmed">32065954</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai R., Niu M., Wang N., Wang Y. Syringin alleviates ovalbumin-induced lung inflammation in BALB/c mice asthma model via NF-kappaB signaling pathway. Environ. Toxicol. 2021;36:433&#x2013;444. doi: 10.1002/tox.23049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/tox.23049</ArticleId><ArticleId IdType="pubmed">33146439</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wu H., Han Z., Sheng H., Wu Y., Wang Y., Guo X., Zhu Y., Li X., Wang Y. Guhong injection promotes post-stroke functional recovery via attenuating cortical inflammation and apoptosis in subacute stage of ischemic stroke. Phytomedicine. 2022;99:154034. doi: 10.1016/j.phymed.2022.154034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2022.154034</ArticleId><ArticleId IdType="pubmed">35276592</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Zhao L., Su Y., Liu X., Zhang F., Gao Y. Syringin Prevents Abeta25-35-Induced Neurotoxicity in SK-N-SH and SK-N-BE Cells by Modulating miR-124-3p/BID Pathway. Neurochem. Res. 2021;46:675&#x2013;685. doi: 10.1007/s11064-021-03240-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-021-03240-1</ArticleId><ArticleId IdType="pubmed">33471295</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.Y., Zhang Q., Xun Z., Yuan L., Li R., Li X., Tian S.Y., Xin N., Xu Y. Increases of iASPP-Keap1 interaction mediated by syringin enhance synaptic plasticity and rescue cognitive impairments via stabilizing Nrf2 in Alzheimer&#x2019;s models. Redox. Biol. 2020;36:101672. doi: 10.1016/j.redox.2020.101672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101672</ArticleId><ArticleId IdType="pmc">PMC7452088</ArticleId><ArticleId IdType="pubmed">32828017</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding H.G., Deng Y.Y., Yang R.Q., Wang Q.S., Jiang W.Q., Han Y.L., Huang L.Q., Wen M.Y., Zhong W.H., Li X.S., et al. Hypercapnia induces IL-1beta overproduction via activation of NLRP3 inflammasome: Implication in cognitive impairment in hypoxemic adult rats. J. Neuroinflammation. 2018;15:4. doi: 10.1186/s12974-017-1051-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-017-1051-y</ArticleId><ArticleId IdType="pmc">PMC5755461</ArticleId><ArticleId IdType="pubmed">29304864</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Chen Y., Wang H., Wei Y., Yuan Y., Zhou Q., Fang F., Shi S., Jiang X., Dong Y., et al. Microglia-derived IL-1beta promoted neuronal apoptosis through ER stress-mediated signaling pathway PERK/eIF2alpha/ATF4/CHOP upon arsenic exposure. J. Hazard Mater. 2021;417:125997. doi: 10.1016/j.jhazmat.2021.125997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhazmat.2021.125997</ArticleId><ArticleId IdType="pubmed">34229406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X.J., Kong K.M., Qi W.L., Ye W.L., Song P.S. Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury. Acta Pharmacol. Sin. 2005;26:934&#x2013;942. doi: 10.1111/j.1745-7254.2005.00152.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1745-7254.2005.00152.x</ArticleId><ArticleId IdType="pubmed">16038625</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon R., Albornoz E.A., Christie D.C., Langley M.R., Kumar V., Mantovani S., Robertson A.A.B., Butler M.S., Rowe D.B., O&#x2019;Neill L.A., et al. Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Sci. Transl. Med. 2018;10:eaah4066. doi: 10.1126/scitranslmed.aah4066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aah4066</ArticleId><ArticleId IdType="pmc">PMC6483075</ArticleId><ArticleId IdType="pubmed">30381407</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>